- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06029283
Dietary Nitrate Functional Gum Effect on Gingivitis and Heart Health
Effect on Oral-cardio Health From Dietary Nitrate Loaded Functional Gum
The purpose of this research is to determine the effects of a chewing gum containing dietary nitrate to gingival and heart health. Dietary nitrates are commonly found in leafy vegetables and beets. The information learned from the study may help further understand the interconnection of oral health and heart health. The study is looking for individuals who present with mild to moderate gum irritation or bleeding.
In the study participants will be randomized into either a group that will use a chewing gum containing dietary nitrate, or use a placebo chewing gum during a three-week period.
Participants in the study will have a simple gingival exam, x-rays if needed, and small samples of saliva and blood collected. All participants will also undergo a routine tooth cleaning. Participants will be asked to breathe in a tube to sample the levels of nitric oxide. Finally, participants will have their heart health measured with a device that is like a blood pressure cuff.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of the project is to characterize, in subjects with gingival inflammation, the effect of a prebiotic dietary nitrate formulated chewing gum on the oral microbiome. In order to assess this, gingival health and parameters related to vascular health are observed:
The study is testing the hypothesize that short term use of functional gum will have improved inflammatory measures of the gingiva and beneficial cardiovascular impact. The study hopes to discover if any observed changes to oral and cardiovascular measures may be associated to changes to oral microbiome composition.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Harlan Shiau
- Phone Number: 410-706-7152
- Email: chewgum4gum@gmail.com
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Recruiting
- University of Maryland School of Dentistry
-
Contact:
- Hee yeon KIm
- Phone Number: 443-231-4556
- Email: chewgum4gum@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult subjects with mild to moderate gingivitis, defined with a MGI score of at least 2.0
- Subjects must have a minimum of 20 natural teeth
- Subjects must be able to chew gum
Exclusion Criteria:
- Significant alveolar bone loss (>3.0 mm CEJ to bone)
- Requirement for antibiotic pre-medication prior to dental procedures
- Systemic antibiotic use in past 14 days to current.
- Use of anti-inflammatory (NSAIDs) or in past 14 days
- Use of anticoagulant therapy or in past 14 days.
- Current smokers
- Pregnancy
- Use of any oral rinses such as, but not limited to chlorhexidine, essential oils, cetylpyridinium chloride during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo arm of non-dietary nitrate gum
Placebo gum with no dietary nitrate
|
placebo chewing gum
|
Experimental: Test arm of dietary nitrate containing gum
Functional gum with dietary nitrate
|
dietary nitrate in a chewing gum delivery vehicle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gingival inflammation
Time Frame: 0 and 21 days
|
Gingival index or similar data collected.
|
0 and 21 days
|
Microbiome profile
Time Frame: 0 and 21 days
|
salivary sample collected
|
0 and 21 days
|
Blood vessel elasticity
Time Frame: 0 and 21 days
|
CV profiler device used
|
0 and 21 days
|
nitric oxide
Time Frame: 0 and 21 days
|
Breathalyzer type test
|
0 and 21 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Harlan Shiau, Clinical Assoc. Prof.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HP-00106795
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular DiseaseUnited States
Clinical Trials on Placebo chewing gum
-
Denver Nephrologists, P.C.CM&D Pharma LimitedCompletedChronic Kidney Disease | HyperphosphatemiaUnited States
-
Medical University of ViennaRecruitingHyperemesis Gravidarum | Nausea Gravidarum | Vitamin C DeficiencyAustria
-
University of PennsylvaniaNot yet recruiting
-
U.S. Army Medical Research and Development CommandCompleted
-
Medical University of ViennaCompletedGestational Diabetes Mellitus in PregnancyAustria
-
Ahmed Salah Ahmed Abd ElgalilCompletedEndotracheal Intubation | Randomized Controlled Trial | Sore Throat | Gum ChewingEgypt
-
Instituto Tecnologico y de Estudios Superiores...Completed
-
University Hospital, LimogesActive, not recruiting
-
Istanbul Demiroglu Bilim UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedPostoperative Ileus | Gynecologic Disease | Paralytic IleusTurkey